Abstract
Background
Hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS), performed using closed-abdomen technique (CAT), may affect intraabdominal pressure (IAP). High IAP may increase postoperative complications due to decreased venous return and hypoperfusion to vital organs. Elevated core body temperature (CBT) may cause multiorgan dysfunction. Low IAP or CBT could result in suboptimal HIPEC and potentially translate into early disease recurrence. The aim of the present study is to identify possible correlations between IAP or CBT and postoperative complications.
Patients and Methods
Continuous intraabdominal pressure measurement was performed by intraabdominal catheter. Inflow temperature was set at 44 °C, and mean perfusate temperature was 42 °C. CBT was measured continuously in the distal esophagus. We compared the rate of postoperative complications between the low IAP group (2–10 mmHg, n = 28), target IAP group (10–20 mmHg, n = 71), and high IAP group (20–34 mmHg, n = 16) as well as with CBT as a continuous variable.
Results
115 patients were included in the study. There was no difference between IAP groups in terms of age, gender, primary diagnosis, operative peritoneal cancer index, CBT, or operative time. There was no correlation between IAP and postoperative complications or with prolonged hospital stay. On multivariate analysis, elevated mean CBT was a positive predictor of postoperative complications (p = 0.035).
Conclusions
IAP level during closed-abdomen technique HIPEC is not associated with postoperative complications. However, elevated CBT may increase postoperative complications.
Similar content being viewed by others
References
Maciver AH, Al-Sukhni E, Esquivel J, Skitzki JJ, Kane JM, Francescutti VA. Current delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS/HIPEC) and perioperative practices: an international survey of high-volume surgeons. Ann Surg Oncol. 2016; https://doi.org/10.1245/s10434-016-5692-3.
Neuwirth MG, Alexander HR, Karakousis GC. Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective. J Gastrointest Oncol. 2016;7(1):18–28. https://doi.org/10.3978/j.issn.2078-6891.2015.106.
Kanakoudis AF, Petrou A, Michaloudis D, Chortaria GKA. Anaesthesia for intra-peritoneal perfusion of hyperthermic chemotherapy. Anaesthesia. 1996;51:1033–36.
Ortega-Deballon P, Facy O, Jambet S, Magnin G, Cotte E, Beltramo JL, Chauffert, et al. Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol. 2010;17(7):1957–63. https://doi.org/10.1245/s10434-010-0937-z.
Elias D, Franc G, Boutitie F, Quenet F, Bereder JM, Baudouin M, Lorimier G. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. 2016;28(1):63–68. https://doi.org/10.1200/jco.2009.23.9285.
Elias D, Antoun S, Goharin A, Otmany AE, Puizillout JM, Lasser P. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig. 2000;1(5):0–1.
Dahl O. Status of clinical hyperthermia. Acta Oncol. 1999; 38: 863–73. https://doi.org/10.1080/028418699432554
Kajdi M, Beck-schimmer B, Held U, Kofmehl R, Lehmann K, Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol. 2014;12(1):1–9. https://doi.org/10.1186/1477-7819-12-136.
Bouchama A, Knochel JP. Heat stroke. N Engl J Med. 2002;346(25):1978–88.
Malbrain MLNG, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, Waele JD, Balogh H, et al. Results from the International Conference of experts on intra-ABDOMINAL hypertension and abdominal compartment syndrome. I. definitions. Intensive Care Med. 2006;32(11):1722–32. https://doi.org/10.1007/s00134-006-0349-5.
Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42.
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae.
Ceelen WP, Flessner MF, et al. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol. 2010;7(2):108–15. https://doi.org/10.1038/nrclinonc.2009.217.
Kusamura S et al. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2008;15;98(4):247–52
Schaaf L, Kuip H, Zopf W, Winter S, Munch M, Murdter T, Thon KP, et al. A temperature of 40 °C appears to be a critical threshold for potentiating cytotoxic chemotherapy in vitro and in peritoneal carcinomatosis patients undergoing HIPEC. Ann Surg Oncol. 2015:758–65. https://doi.org/10.1245/s10434-015-4853
Sessler DI. Perioperative thermoregulation and heat balance. Lancet. 2017;387(10038):2655–64. https://doi.org/10.1016/s0140-6736(15)00981-2.
Pelz JOW, Doerfer J, Decker M, Dimmler A, Hohenberger W, Meyer T. Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model. Int J Colorectal Dis. 2007:22:941–47. https://doi.org/10.1007/s00384-006-0246-y.
Lepock JR. How do cells respond to their thermal environment? Int J Hyperthermia. 2005;20:8. https://doi.org/10.1080/02656730500307298
Samel S, Singal A, Becker H, Post S, Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer. Eur J Surg Oncol. 2000; 26: 222–26. https://doi.org/10.1053/ejso.1999.0780.
Westermann AM, Wiedemann GJ, Jager E, Jager D, Katschinski DM, Knuth A, Vörde sive Vörding PZ. A Systemic Hyperthermia Oncologic Working Group trial. Oncology. 2003;53792:312–21. https://doi.org/10.1159/000070287.
Esquis P, Consolo D, Magnin G, Pointaire P, Moretto P, Ynsa MD, Beltramo JL, et al. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244(1):106–112. https://doi.org/10.1097/01.sla.0000218089.61635.5f.
Facy O, Samman S, Magnin G, Ghiringhelli F, Ladoire S, Chauffert B, Rat P, Ortega-Deballon P. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin. Ann Surg. 2012;0(0):1. https://doi.org/10.1097/sla.0b013e3182582b38.
Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol. 2008;15(1):339–44. https://doi.org/10.1245/s10434-007-9571-9.
Malbrain MLNG. Different techniques to measure intra-abdominal pressure (IAP): time for a critical re-appraisal. Appl Physiol Intensive Care Med 2 Physiol Rev Ed. 2012:13–27. https://doi.org/10.1007/978-3-642-28233-1_2.
Chopra SS, Wolf S, Rohde V, Freimann FB. Pressure measurement techniques for abdominal hypertension: conclusions from an experimental model. Crit Care Res Pract. 2015; https://doi.org/10.1155/2015/278139.
Disclosures
The authors have no commercial disclosures relevant to this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goldenshluger, M., Zippel, D., Ben-Yaacov, A. et al. Core Body Temperature but Not Intraabdominal Pressure Predicts Postoperative Complications Following Closed-System Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Administration. Ann Surg Oncol 25, 660–666 (2018). https://doi.org/10.1245/s10434-017-6279-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-017-6279-3